Skip to main content
. Author manuscript; available in PMC: 2016 Mar 1.
Published in final edited form as: J Acquir Immune Defic Syndr. 2015 Mar 1;68(3):245–249. doi: 10.1097/QAI.0000000000000482

Figure 1. Antiretroviral use and projected mother-to-child transmission, LOESS regression.

Figure 1

Trends in antiretroviral use among HIV-infected pregnant women during the surveillance period, demonstrating increases both in the proportion of women receiving combination ART and no antenatal antiretrovirals, Panel A. Corresponding increases in projected MTCT during in the initial implementation of Option B as demonstrated by solid line (Spectrum base inputs) and dotted lines (high and low Spectrum inputs), Panel B. Projected MTCT adjusted for delivery site.